Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: A prognostic study | Lippert J, et al | European Journal of Endocrinology | Aug. 2023

Nonacus product: Germline


Adrenocortical carcinoma (ACC) is a rare aggressive malignancy with heterogeneous clinical outcomes. Recent studies proposed a combination of clinical/histopathological parameters (S-GRAS score) or molecular biomarkers (BMs) to improve prognostication. We performed a comparative analysis of DNA-based BMs by evaluating their added prognostic value to the S-GRAS score.